Clinical Trials Browser

Phase 2 × Melanoma × Dactinomycin × Clear all

NCT01323517 2018-05-15

Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity

Phase 2 Completed

26 enrolled 11 charts

Melanoma

NCT00004250 2013-01-16

Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

Phase 2 Completed

DermatologicSarcoma

Melanoma, Sarcoma